Regenerative Medical Technology Group Seeks 4x Increase in Authorized Shares to Cover Massive Dilution Overhang
RMTG has more than doubled off its 52-week low of $0.019 on elevated volume (3.3× avg).
Summary
Regenerative Medical Technology Group is quadrupling its authorized common shares to 400 million to cover a massive overhang of convertible securities and warrants, potentially diluting existing shareholders by over 1,300%.
Key Events · Financing and Capital Events · RMTG
-
Authorized Shares Quadrupled
Board and majority stockholders approved increasing authorized common shares from 100 million to 400 million, effective upon filing with Nevada Secretary of State.
-
Massive Dilution Overhang
Approximately 184.2 million shares are potentially issuable upon conversion/exercise of outstanding convertible notes, Series CC and DD preferred stock, and warrants, versus only 13.1 million shares currently outstanding.
-
Going Concern and Debt Defaults
The company reiterated its going concern warning in its latest 10-Q and disclosed massive debt defaults and acceleration risk, making this capital increase a likely precursor to further dilutive financing.
-
Majority Stockholder Control
Benito Novas and Dave Christensen, holding 67% of voting power via Series AA Preferred Stock, approved the action without a shareholder meeting.
Analysis · RMTG · Trade & Services
The company is increasing authorized common shares from 100 million to 400 million to accommodate approximately 184 million shares potentially issuable upon conversion of outstanding convertible notes, preferred stock, and warrants. This is a highly dilutive move that could more than triple the current outstanding share count of 13.1 million. The company is already in financial distress with a going concern warning and massive debt defaults, so this capital increase is likely a precursor to further dilutive financing. The majority stockholders, who control 67% of voting power, approved the action without a shareholder meeting.
At the time of this filing, RMTG was trading at $0.05 on OTC in the Trade & Services sector, with a market capitalization of approximately $696.4K. The 52-week trading range was $0.02 to $0.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.